METTL3 and colorectal carcinoma: Moreover, methylation on p53 pre-mRNA catalyzed by METTL3 promotes a preferential splicing, inducing p53 R273H mutant protein, and giving rise to multidrug resistance in CRC cells, such as Oxa and 5-FU [65].